What can be done to improve polycystic ovary syndrome (PCOS) healthcare? Insights from semi-structured interviews with women in Canada.
Health care
Health services
Improvement
Interviews
Lived experiences
PCOS
Polycystic ovary syndrome
Reform
Journal
BMC women's health
ISSN: 1472-6874
Titre abrégé: BMC Womens Health
Pays: England
ID NLM: 101088690
Informations de publication
Date de publication:
10 05 2022
10 05 2022
Historique:
received:
05
08
2021
accepted:
25
04
2022
entrez:
10
5
2022
pubmed:
11
5
2022
medline:
14
5
2022
Statut:
epublish
Résumé
Polycystic ovary syndrome (PCOS) is a common and perplexing condition affecting metabolic, reproductive, cardiovascular, and psychological health in women. Previous studies point to widespread dissatisfaction and frustration in women with the information and care they receive. Studies have found delays with the diagnosis of PCOS and gaps in knowledge in physicians regarding the diagnosis and management of PCOS. Little has been heard from women on what they think can be improved with PCOS care, especially in Canada. This qualitative study explores women's experiences navigating the healthcare system and their insights on what could be improved based on their lived experiences. Twenty-five participants were interviewed remotely over the phone by the first author between October and December 2018.Interviews were semi-structured and in-depth. Data were analyzed using thematic analysis and interpretive description methodology. Twenty-five in-depth interviews conducted with participants across Canada (ages 18-63) revealed three overall areas in need of improvement. First, women emphasized a need for greater knowledge and awareness of PCOS in primary care physicians (PCPs) as well as the need for the medical community to prioritize women's health. Second, participants advocated for greater PCOS awareness and de-stigmatization in the general community and in women and girls, and any individuals with female reproductive systems. Third, participants brought up several needed resources, such as the need for more PCOS research to be funded and undertaken, more PCOS specialists and experts to be available, credible doctor-provided information (e.g., pamphlets, websites), and age-specific support groups and mental health supports to be available. Participants were generally unaware of existing PCOS organizations and brought up the need for established PCOS organizations to aid in the training and retraining of doctors and local awareness-building in communities. Participants believed that PCPs in Canada needed to be well-versed on how to diagnose and manage PCOS to prevent delays in diagnosis and provide easier access to care. Further, greater awareness and de-stigmatization in the general community are needed so women can identify symptoms early and have access to support from those around them. Overall, PCOS may be an overlooked and under-prioritized condition, both in the Canadian healthcare system and general community.
Sections du résumé
BACKGROUND
Polycystic ovary syndrome (PCOS) is a common and perplexing condition affecting metabolic, reproductive, cardiovascular, and psychological health in women. Previous studies point to widespread dissatisfaction and frustration in women with the information and care they receive. Studies have found delays with the diagnosis of PCOS and gaps in knowledge in physicians regarding the diagnosis and management of PCOS. Little has been heard from women on what they think can be improved with PCOS care, especially in Canada. This qualitative study explores women's experiences navigating the healthcare system and their insights on what could be improved based on their lived experiences.
METHODS
Twenty-five participants were interviewed remotely over the phone by the first author between October and December 2018.Interviews were semi-structured and in-depth. Data were analyzed using thematic analysis and interpretive description methodology.
RESULTS
Twenty-five in-depth interviews conducted with participants across Canada (ages 18-63) revealed three overall areas in need of improvement. First, women emphasized a need for greater knowledge and awareness of PCOS in primary care physicians (PCPs) as well as the need for the medical community to prioritize women's health. Second, participants advocated for greater PCOS awareness and de-stigmatization in the general community and in women and girls, and any individuals with female reproductive systems. Third, participants brought up several needed resources, such as the need for more PCOS research to be funded and undertaken, more PCOS specialists and experts to be available, credible doctor-provided information (e.g., pamphlets, websites), and age-specific support groups and mental health supports to be available. Participants were generally unaware of existing PCOS organizations and brought up the need for established PCOS organizations to aid in the training and retraining of doctors and local awareness-building in communities.
CONCLUSIONS
Participants believed that PCPs in Canada needed to be well-versed on how to diagnose and manage PCOS to prevent delays in diagnosis and provide easier access to care. Further, greater awareness and de-stigmatization in the general community are needed so women can identify symptoms early and have access to support from those around them. Overall, PCOS may be an overlooked and under-prioritized condition, both in the Canadian healthcare system and general community.
Identifiants
pubmed: 35538531
doi: 10.1186/s12905-022-01734-w
pii: 10.1186/s12905-022-01734-w
pmc: PMC9092874
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
157Informations de copyright
© 2022. The Author(s).
Références
J Obstet Gynecol Neonatal Nurs. 2011 Nov-Dec;40(6):709-18
pubmed: 22092488
J Transcult Nurs. 2020 Mar;31(2):162-170
pubmed: 31204601
Nutr Res Rev. 2017 Jun;30(1):97-105
pubmed: 28222828
Gynecol Endocrinol. 2021 May;37(5):392-405
pubmed: 33355023
BMC Womens Health. 2020 Oct 2;20(1):221
pubmed: 33008386
Health Psychol Open. 2015 Aug 31;2(2):2055102915603051
pubmed: 28070371
Health Soc Work. 2020 Jan 7;45(1):40-46
pubmed: 31953536
Soc Sci Med. 2002 Feb;54(3):349-61
pubmed: 11824912
Br J Gen Pract. 2020 Apr 30;70(694):e322-e329
pubmed: 32152043
Gynecol Endocrinol. 2020 Oct;36(10):854-859
pubmed: 32252571
Fertil Steril. 2017 Jun;107(6):1380-1386.e1
pubmed: 28483503
J Adv Nurs. 2009 Oct;65(10):2046-55
pubmed: 19686401
BMC Womens Health. 2013 Dec 17;13:51
pubmed: 24341398
BMC Womens Health. 2007 Jun 20;7:9
pubmed: 17578583
J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1071-e1083
pubmed: 33211867
Reprod Biomed Online. 2018 Oct;37(4):498-504
pubmed: 30228071
Int J Womens Health. 2020 Oct 28;12:927-938
pubmed: 33149703
Hum Reprod. 2017 May 1;32(5):1075-1091
pubmed: 28333286
Hum Reprod. 2004 Jan;19(1):41-7
pubmed: 14688154
J Med Internet Res. 2016 Jun 02;18(6):e89
pubmed: 27255809
Obes Rev. 2020 Oct;21(10):e13046
pubmed: 32452622
Commun Med. 2012;9(2):125-31
pubmed: 24498697
Health Care Women Int. 2017 Feb;38(2):167-186
pubmed: 27630044
Minerva Obstet Gynecol. 2022 Feb;74(1):45-59
pubmed: 33876903
J Holist Nurs. 2011 Dec;29(4):256-66
pubmed: 21357181
Patient Educ Couns. 2022 Mar;105(3):719-725
pubmed: 34099308
Endocr Pract. 2015 Nov;21(11):1291-300
pubmed: 26509855
Hum Reprod Open. 2018 Nov 08;2018(4):hoy019
pubmed: 30895260
PLoS One. 2019 Dec 26;14(12):e0226074
pubmed: 31877155
J Clin Endocrinol Metab. 2017 Dec 1;102(12):4421-4427
pubmed: 29092064
Arch Gynecol Obstet. 2020 Feb;301(2):619-626
pubmed: 31776708
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
J Endocr Soc. 2018 Aug 01;2(9):1001-1009
pubmed: 30140785
Health Qual Life Outcomes. 2017 Aug 18;15(1):162
pubmed: 28821294
Qual Health Res. 2021 Feb;31(3):523-534
pubmed: 33213256
J Hum Reprod Sci. 2019 Oct-Dec;12(4):287-293
pubmed: 32038077
J Ovarian Res. 2021 Feb 3;14(1):25
pubmed: 33536040
Am Fam Physician. 2019 Aug 1;100(3):168-175
pubmed: 31361105
J Clin Endocrinol Metab. 2017 Feb 1;102(2):604-612
pubmed: 27906550
J Adv Nurs. 2020 Jul;76(7):1728-1736
pubmed: 32215949
Semin Reprod Med. 2018 Jan;36(1):19-27
pubmed: 30189447
J Adv Nurs. 2017 Oct;73(10):2318-2326
pubmed: 28329428
Ann Endocrinol (Paris). 2020 Oct;81(5):487-492
pubmed: 32827451
Fertil Steril. 2021 Jun;115(6):1557-1568
pubmed: 33602559
J Health Psychol. 2016 Jun;21(6):1170-82
pubmed: 25205774
Fertil Steril. 2019 Aug;112(2):353-361
pubmed: 31056307
Semin Reprod Med. 2018 Jan;36(1):35-41
pubmed: 30189449
Semin Reprod Med. 2018 Jan;36(1):50-58
pubmed: 30189451
Hum Reprod. 2018 Sep 1;33(9):1602-1618
pubmed: 30052961
J Med Internet Res. 2020 Apr 21;22(4):e16541
pubmed: 32314967
J Clin Med. 2018 Oct 28;7(11):
pubmed: 30373317
Geburtshilfe Frauenheilkd. 2012 Nov;72(11):1009-1017
pubmed: 25258457
Hum Reprod. 2016 Dec;31(12):2841-2855
pubmed: 27664216
Med J Aust. 2018 Oct 1;209(S7):S3-S8
pubmed: 30453865
Semin Reprod Med. 2018 Jan;36(1):5-12
pubmed: 30189445
Int J Adolesc Med Health. 2020 Jun 08;33(3):123-126
pubmed: 32549137
Fertil Steril. 2019 Nov;112(5):930-938.e1
pubmed: 31395311
Singapore Med J. 2018 Nov;59(11):567-571
pubmed: 30498839